Covaxin Trial Data, WHO Approval Timeline, and Controversy
Official Phase III data released by Bharat Biotech and ICMR confirm Covaxin's safety and an efficacy range of 78% against symptomatic COVID-19. Readers will discover how this evidence aligns with...